SONOSCAPE MEDICAL CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.19 CNY | +0.98% |
|
+11.41% | -12.92% |
| Apr. 26 | SonoScape Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 12 | Sonoscape Medical Corp. Proposes Dividend for 2023 | CI |
| Sales 2024 * | 341M 2.47B | Sales 2025 * | 447M 3.24B | Capitalization | 2.44B 17.69B |
|---|---|---|---|---|---|
| Net income 2024 * | 73M 529M | Net income 2025 * | 102M 739M | EV / Sales 2024 * | 6.26 x |
| Net cash position 2024 * | 307M 2.23B | Net cash position 2025 * | 376M 2.72B | EV / Sales 2025 * | 4.62 x |
| P/E ratio 2024 * |
30.4
x | P/E ratio 2025 * |
23.8
x | Employees | 2,697 |
| Yield 2024 * |
0.65% | Yield 2025 * |
0.8% | Free-Float | 44.4% |
More Fundamentals
* Assessed data
More news
More recommendations
More news
| 1 day | +0.98% | ||
| 1 week | +11.41% | ||
| Current month | +8.39% | ||
| 1 month | +6.54% | ||
| 3 months | +7.60% | ||
| 6 months | -8.97% | ||
| Current year | -12.92% |
1 week
36.58
41.40
1 month
34.6041.40
Current year
31.6147.50
1 year
31.6162.62
3 years
23.3562.62
5 years
20.0662.62
10 years
6.2862.62
| Managers | Title | Age | Since |
|---|---|---|---|
Kun Xiang Wu
FOU | Founder | 60 | 02-09-26 |
Yue Zuo Luo
DFI | Director of Finance/CFO | 41 | 11-12-31 |
Nai Zhang Feng
CTO | Chief Tech/Sci/R&D Officer | 49 | 12-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Chen
FOU | Founder | 59 | 02-09-26 |
Kun Xiang Wu
FOU | Founder | 60 | 02-09-26 |
Yi Bo Huang
BRD | Director/Board Member | 57 | 01-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 41.19 | +0.98% | 3,934,782 |
| 24-04-25 | 40.79 | +3.45% | 4,852,482 |
| 24-04-24 | 39.43 | +0.08% | 3,398,100 |
| 24-04-23 | 39.4 | +5.60% | 5,097,600 |
| 24-04-22 | 37.31 | +0.92% | 2,614,009 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Sonoscape Medical Corp is a company engaged in research, development, production and sales of medical diagnostic and therapeutic equipment. The Company's main products are medical ultrasound diagnostic equipment, such as color Doppler ultrasound diagnostic equipment and B-type ultrasound diagnostic equipment, medical electronic endoscope equipment and consumables, as well as blood analyzers.
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
41.19
CNY
Average target price
50.14
CNY
Spread / Average Target
+21.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.92% | 2.44B | |
| -5.77% | 14.68B | |
| -40.71% | 2.71B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +91.79% | 502M | |
| +1.67% | 183M | |
| -.--% | 168M | |
| -29.34% | 161M |
- Stock Market
- Equities
- 300633 Stock
